Durham company Aerie Pharmaceuticals Inc. (AERI:NMQ) working in Pharmaceuticals and Biotechnology sees value fall 13.6% in week ending Oct. 1

0Comments

Value in Pharmaceuticals and Biotechnology stocks rose 1.7 percent in the week ending Oct. 1 from the previous week.

The strongest performing Pharmaceuticals and Biotechnology company in North Carolina was 9 Meters Biopharma Inc. (NMTR:NAQ), sitting 108.3 percent higher to sell at $0.215.

Novan Inc. (NOVN:NAQ) fared the worst among North Carolina companies, suffering an 82.5 percent drop to $1.87.

Among Durham companies, Chimerix Inc. (CMRX:NMQ) saw the highest rise in value of 22.9 percent in the week ending Oct. 1.

The Telecommunications Equipment industry was the week’s best-performing industry on the market. The market is divided into 42 different industries.

Alternative Energy was the worst-performing industry.

Healthcare and technology stocks are viewed as the safest bets for long-term gains.

Besty Kuekcer with Benzinga.com said healthcare-related stocks, such as hospital conglomerates and insurance companies, have weathered numerous economic crises and still make a profit, suggesting that they are generally a stable investment.

While technology stocks can be more risky, given the boom-bust nature of new tech companies, Kuecker recommended a diverse portfolio of tech companies to strike it big when companies succeed or sell to other larger companies.

For short-term investments, Kuecker recommended “consumer discretionary” stocks, which are sensitive to economic changes but can rise greatly on the back of a strong economy.

Nothing in this article is to be assumed as financial advice.

Individual companies can have several different types of shares across many stock markets. It is possible for different types of shares to see different results on the market.

Rank of stock market industries in week ending Oct. 1

Industry Percentage Change Highest Positive Change Largest Negative Change
Telecommunications Equipment 6.4% 355.9% -83.3%
Oil, Gas and Coal 6% 1,087.1% -99.9%
Beverages 5% 3,444.5% -99.4%
Precious Metals and Mining 3% 43.5% -68.8%
Pharmaceuticals and Biotechnology 1.7% 2,782.7% -98.9%
Non-life Insurance 1.1% 824.8% -66.6%
Software and Computer Services 0.7% 1,304.2% -99.9%
Food Producers 0.7% 2,803.1% -99.9%
Industrial Transportation 0.5% 344% -99.7%
Investment Banking and Brokerage Services 0.5% 837.2% -96.5%
Open End and Miscellaneous Investment Vehicles 0.2% 15,034,940% -99.9%
Consumer Services -0.3% 793.8% -99.9%
Industrial Engineering -0.4% 2,045.6% -66.4%
Chemicals -0.9% 9,519.5% -99.9%
General Industrials -0.9% 597.7% -92%
Industrial Materials -1.2% 57.5% -90%
Life Insurance -1.3% 185.5% -99.9%
Industrial Support Services -1.5% 3,075.4% -99.9%
Retailers -1.5% 430.6% -93.6%
Aerospace and Defense -1.7% 709% -93%
Leisure Goods -1.8% 2,345,941.1% -99.7%
Waste and Disposal Services -2.1% 286.4% -88.5%
Household Goods and Home Construction -2.1% 851.9% -99.9%
Banks -2.3% 14,572.7% -97.7%
Finance and Credit Services -2.5% 228% -94.7%
Closed End Investments -2.6% 2,272.2% -99.9%
Real Estate Investment and Services -2.7% 303,091.5% -99.7%
Automobiles and Parts -2.7% 66.3% -79.6%
Industrial Metals and Mining -2.7% 2,007.8% -99.9%
Health Care Providers -3.1% 424.1% -99.1%
Personal Care, Drug and Grocery Stores -3.4% 168.4% -77.4%
Real Estate Investment Trusts -3.9% 1,068.6% -78%
Media -6.3% 188.5% -99.5%
Medical Equipment and Services -7.4% 4,146.1% -99.9%
Personal Goods -7.4% 357.1% -99.7%
Telecommunications Service Providers -7.6% 112.9% -58.9%
Gas, Water and Multi-utilities -7.8% 1,657.5% -60.3%
Electricity -8.4% 1,615.9% -72.1%
Mortgage Real Estate Investment Trusts -10% 166.8% -99.8%
Tobacco -11.8% 2,108.8% -91.4%
Travel and Leisure -12.5% 9,006.3% -92.8%
Alternative Energy -46.5% 290.8% -73.7%


Related

Craig T. Albanese, CEO

Duke Health trial finds immunotherapy delays chemotherapy in advanced colorectal cancer

A new clinical trial from Duke Health shows that first-line immunotherapy may delay or replace chemotherapy in advanced colorectal cancer cases. The findings offer hope for improved quality of life among younger patients facing aggressive forms of the disease.

Hannah Lohman, RTI Research Environmental Engineer

EPA and HHS announce actions to address microplastics in drinking water

The EPA and HHS have announced new efforts targeting microplastics in U.S. drinking water systems. RTI International staff attended as federal officials detailed regulatory plans prioritizing research funding into detection methods, impacts on health, prevention strategies, and laboratory standards.

Tim J. Gabel, President and Chief Executive Officer

RTI International examines trends and shifts in ultra-processed food consumption

RTI International highlights rising consumer awareness about ultra-processed foods (UPFs) alongside industry reformulations and emerging state-level policies restricting certain additives. The organization points out challenges surrounding inconsistent definitions while noting increased calls for transparency from both regulators and public health advocates.

Trending

The Weekly Newsletter

Sign-up for the Weekly Newsletter from Durham Reporter.